KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShort-Term Debt repayments
Ratios

Pfizer (PFE) Shares Issued (2016 - 2020)

Pfizer (PFE) has disclosed Shares Issued for 9 consecutive years, with $206.0 million as the latest value for Q3 2020.

  • Quarterly Shares Issued rose 274.55% to $206.0 million in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $455.0 million through Sep 2020, down 1.73% year-over-year, with the annual reading at $425.0 million for FY2020, 7.87% up from the prior year.
  • Shares Issued for Q3 2020 was $206.0 million at Pfizer, up from $34.0 million in the prior quarter.
  • The five-year high for Shares Issued was $625.0 million in Q3 2018, with the low at $34.0 million in Q2 2020.
  • Average Shares Issued over 5 years is $205.2 million, with a median of $160.0 million recorded in 2018.
  • The sharpest move saw Shares Issued plummeted 91.2% in 2019, then surged 274.55% in 2020.
  • Over 5 years, Shares Issued stood at $73.0 million in 2016, then soared by 182.19% to $206.0 million in 2017, then decreased by 22.33% to $160.0 million in 2018, then plummeted by 43.12% to $91.0 million in 2019, then skyrocketed by 126.37% to $206.0 million in 2020.
  • According to Business Quant data, Shares Issued over the past three periods came in at $206.0 million, $34.0 million, and $124.0 million for Q3 2020, Q2 2020, and Q1 2020 respectively.